SEC Form 4 · accession 0001127602-16-066793
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vecheslav A Elagin
Officer — EVP, Research & Development
Period of report
Nov 9, 2016
Accepted (ET)
Nov 14, 2016 · 9:28 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2016 | A | 10,000 | $0.00 | A | 60,809 | D | |
| Common StockF2 | Nov 9, 2016 | A | 10,000 | $0.00 | A | 70,809 | D | |
| Common StockF3 | Nov 10, 2016 | D | 10,000 | $0.00 | D | 60,809 | D | |
| Common Stock | holding | — | — | — | 75 | I | Held in Meridian Savings & Investment Plan (401K) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (or 100%) on November 15, 2020.
- F2These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest 25% per year over four years, subject to attainment of a specified earnings target for fiscal 2017.
- F3These restricted stock units were awarded under the 2012 Stock Incentive Plan and were subject to attainment by the Company of a specified earnings target for fiscal 2016. As the Company did not reach the target, these restricted stock units have been cancelled.